本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tiziana Life Sciences PLC

1.09
-0.1000-8.40%
盘后:1.090.00000.00%19:30 EDT
成交量:56.76万
成交额:63.10万
市值:1.38亿
市盈率:-7.00
高:1.20
开:1.20
低:1.07
收:1.19
52周最高:2.25
52周最低:0.7615
股本:1.27亿
流通股本:6,383.25万
量比:0.68
换手率:0.89%
股息:- -
股息率:- -
每股收益(TTM):-0.1558
每股收益(LYR):-0.1558
净资产收益率:-924.32%
总资产收益率:-115.96%
市净率:2662.12
市盈率(LYR):-7.00

数据加载中...

2020/04/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/17

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/02/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]